Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Pernkopf

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Endocrinology|June 18, 2010
Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasiaChristoph Zenzmaier, Natalie Sampson, Dominik Pernkopf, et al.
The Journal of Urology|September 8, 2005
Uroflow nomogram for male adolescentsDominik Pernkopf, Eugen Plas, Thomas Lang, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Endocrinology|June 18, 2010
Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasiaChristoph Zenzmaier, Natalie Sampson, Dominik Pernkopf, et al.
The Journal of Urology|September 8, 2005
Uroflow nomogram for male adolescentsDominik Pernkopf, Eugen Plas, Thomas Lang, et al.
Pageof 1